Legend Biotech Sets Shareholder Meeting for Oct 21
Ticker: LEGN · Form: 6-K · Filed: Sep 20, 2024 · CIK: 1801198
| Field | Detail |
|---|---|
| Company | Legend Biotech Corp (LEGN) |
| Form Type | 6-K |
| Filed Date | Sep 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
Legend Biotech shareholder meeting is Oct 21st, mark your calendars.
AI Summary
Legend Biotech Corporation announced on September 20, 2024, that its Annual General Meeting of Shareholders will be held on October 21, 2024, at 9:30 a.m. local time at the company's offices located at 2101 Cottontail Lane, Somerset, New Jersey.
Why It Matters
This filing informs shareholders about the upcoming annual meeting where key corporate decisions and elections will likely take place.
Risk Assessment
Risk Level: low — This is a routine corporate filing announcing a shareholder meeting, with no immediate financial or operational risks disclosed.
Key Players & Entities
- Legend Biotech Corporation (company) — Registrant
- October 21, 2024 (date) — Annual General Meeting date
- September 20, 2024 (date) — Date of Report
- 2101 Cottontail Lane, Somerset, New Jersey (location) — Company's principal executive office and meeting location
FAQ
When is Legend Biotech Corporation's Annual General Meeting of Shareholders?
The Annual General Meeting of Shareholders is scheduled for October 21, 2024.
Where will the Annual General Meeting be held?
The meeting will be held at the Company's offices at 2101 Cottontail Lane, Somerset, New Jersey.
What time does the meeting start?
The meeting will begin at 9:30 a.m. local time.
What form does Legend Biotech file its annual reports under?
Legend Biotech files its annual reports under Form 20-F.
What is the Commission File Number for Legend Biotech?
The Commission File Number for Legend Biotech is 001-39307.
Filing Stats: 346 words · 1 min read · ~1 pages · Grade level 10.9 · Accepted 2024-09-20 08:01:49
Filing Documents
- d843406d6k.htm (6-K) — 12KB
- d843406dex991.htm (EX-99.1) — 60KB
- d843406dex992.htm (EX-99.2) — 12KB
- d843406dex993.htm (EX-99.3) — 25KB
- d843406dex994.htm (EX-99.4) — 25KB
- 0001193125-24-222460.txt ( ) — 134KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. LEGEND BIOTECH CORPORATION (Registrant) September 20, 2024 By: /s/ Ying Huang Ying Huang, Ph.D. Chief Executive Officer